Wragge Lawrence Graham & Co
- Company/Commercial (105)
- Employment (82)
- Intellectual Property (69)
- Real Estate (60)
- Banking / Finance (42)
- Corporate (41)
- Financial services (35)
- Construction (32)
- Insolvency & restructuring (32)
- In-House (25)
- Regulatory and compliance (25)
- Crime (20)
- Planning (18)
- Information Technology (16)
- Pharma/Biotech (16)
- Tax (16)
- Public Sector/Local Authority (15)
- Healthcare (14)
- Pensions (14)
- Funds (13)
- Human Rights (12)
- Insurance/reinsurance (12)
- Competition/EU (10)
- Media/Entertainment/Sport (10)
- Family (9)
- Environment (8)
- Private Equity (8)
- Professional Indemnity/Negligence (8)
- Personal tax / Trusts (7)
- Commodities (6)
- Business Tax (5)
- Energy (5)
- PPP/PFI/Commercial projects (5)
- Telecoms (5)
- Privacy and reputation (4)
- Private Client (4)
- Clinical/Medical Negligence (3)
- Personal Injury (3)
- Transport (Including aviation and shipping) (3)
- Charities (1)
- Travel and Tourism (1)
Sort By: Newest first | Oldest first
Common issues that can arise when signing contracts with overseas companies.
Good news for those selling copies of iconic works as proposed repeal is put on back burner;...
MoJ consults on identifying sources of funding in judicial review proceedings.
How the Government plans to ”protect public services against strikes”.
Community trademarks: what is the territorial extent of the requirement for use and acquired distinctiveness?
Two recent decisions of the Intellectual Property Enterprise Court have raised interesting questions about the territorial requirements for use of CTMs by the proprietor.
Also: reporting unenforceable credit agreements; ADR directive; and more.
The US Supreme Court was invited to overturn Brulotte, which would have aligned its licensing law with Europe. It failed to do so.
There is often confusion as to what exactly a net contribution clauses is, and its effect in a construction contract. In this article, Wragges sets out the basics and address some of the common misconceptions in this area.
Ruling on an application for specific disclosure could have big implications in the early stages of procurement disputes.
Hospira v Genentech III: Swiss form claim obvious in view of paper reporting the existence of Phase III trial
Arnold J has delivered the latest blow in the ongoing saga surrounding trastuzumab (the monoclonal antibody in Herceptin) and Hospira’s continued efforts to knock out Genentech’s patents.
In a dispute between Smith & Nephew and ConvaTech, the CoA has ruled that “between 1 per cent and 25 per cent” extends to all values = 0.5 per cent and <25.5 per cent.
The Court of Appeal looked at when a public body is required to appoint new decision makers where a decision has been held to be unlawful and is remitted to the body to be retaken.
Wragge Lawrence Graham & Co’s finance litigation experts bring you the latest on the cases and issues affecting the lending industry.
Eli Lilly succeeds in overturning award of DNIs regarding UK, FR, IT and ES designations of its European patent
The Court of Appeal has delivered its long-awaited judgment in the Actavis v Eli Lillydispute, ruling that Actavis is not entitled to a declaration of noninfringement (DNI) of Eli Lilly’s European patent.
Disputes are time-consuming and costly. This from Wragges’ Back to Basics series sets out some practical tips on straightforward steps you can take to help minimise your exposure to disputes and claims.
The General Court (Third Chamber) in Luxembourg has ruled that Lego’s mannequin shape CTM is valid. The good news for Lego follows the General Court’s 2008 decision that its registration for its brick shape was invalid.
The Supreme Court has given judgment in the first case it has considered arising out of statutory adjudication pursuant to the Housing Grants, Construction and Regeneration Act 1996.
Advocate General Wathelet’s Opinion, of 11 June 2015, indicates that Nestlé’s unbranded KitKat finger shape will not be registrable as a trademark in the UK.
In the first of a two-part series Wragges takes a look at whether a US stock-option-linked non-compete clause will be effective to restrain an executive in a UK subsidiary. There is a good chance the answer is no.
Continuing our back to basics series, Wragges considers some of the practical points to consider if you think a dispute may be looming.